Raymond James Financial
VIVS

Raymond James Financial’s VivoSim Labs VIVS Stock Holding History

Raymond James Financial’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,313
Closed -$4.87K – 7022
2025
Q2 		$4.87K Buy
+3,313
New +$6.07K ﹤0.01% 6181
2025
Q1 		– Sell
-3,299
Closed -$18.2K – 4987
2024
Q4 		$18.2K Buy
+3,299
New +$16.7K ﹤0.01% 4733

Other funds holding VIVS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Raymond James Financial's VIVS Position: Q3 2025 in Review

Raymond James Financial sold out of VivoSim Labs (VIVS) in Q3 2025, closing a stake of 3,313 shares — an estimated $4.87K sold.

Raymond James Financial first reported a position in VIVS in Q4 2024 and held it in 2 quarters. The position peaked at $18.2K in Q4 2024. 29 funds tracked by Wall St. Rank hold VIVS as of Q3 2025.

  • Raymond James Financial reported no remaining VivoSim Labs position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 3,313 VivoSim Labs shares in Q3 2025, an estimated $4.87K.
  • Raymond James Financial first reported a position in VivoSim Labs in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's VivoSim Labs position peaked at $18.2K in Q4 2024.
  • 29 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.